site stats

Signpath pharma

WebMay 12, 2024 · SignPath Pharma, Inc. - Most recent fund raising on May 12, 2024 raised $1,561,000 in Equity. FormDs.com . Newest; Filter; Local; SignPath Pharma, Inc. Industry: Pharmaceuticals (See others in industry) Address: 7984 South 1300 East Sandy, UT, 84094 Phone: 801-245-0313 . Filings. Date Filing Type Reported Sold Incremental Cash WebSignPath Pharma Inc. 105 followers on LinkedIn. SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company. SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and …

Why You Need to Try Calcium/Magnesium Butyrate Supplements Today

WebFind company research, competitor information, contact details & financial data for Signpath Pharma, Inc. of Sandy, UT. Get the latest business insights from Dun & Bradstreet. WebAug 9, 2010 · SignPath Pharma has provided partial support for these studies through offsetting the costs of polymer synthesis. S. Bisht, G. Feldman, and An. Maitra have filed a patent application (U.S. 2008/0107749) that is relevant to the formulation described in … how fix time https://karenmcdougall.com

SignPath Pharma - Overview, News & Competitors ZoomInfo.com

WebSignpath Pharma Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2024-04-09 Filing date … WebSignPath Pharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062024 Prices from USD $250. SummarySignPath Pharma Inc SignPath is a … WebOct 20, 2014 · A high-level overview of Signpath Pharma, Inc. (SGTH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. how fix stripped thread

Sign Path Pharma Inc - 1375 California Rd, Quakertown, PA 18951

Category:SignPath Pharma, Inc. - fund raising filing

Tags:Signpath pharma

Signpath pharma

Signpath Pharma, Inc. Company Profile Sandy, UT Competitors ...

WebSignPath Pharma develops curcumin based drugs to treat cancer and cardiac side effects. The company is investigating its lead products SPP4040, a cancer supportive care drug to reduce cardiomyopathy caused due to cancer chemotherapy; and LipoCurc, a liposomal synthetic curcumin formulation targeting glioblastoma, multiple myeloma, and other … WebSignPath Pharma has begun efforts to develop Lipocurc, an intravenous liposomal curcumin formulation, to treat acute respiratory distress syndrome (ARDS) caused by Covid-19.

Signpath pharma

Did you know?

WebSignPath at Utah Life Science Summit 2024 WebMar 17, 2024 · SignPath Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of heart safe drugs for the treatment of serious diseases. …

WebSignpath Pharma General Information. Description. Operator of a drug development platform intended to eliminate the cardiac side effects of the drugs. The company is involved in developing products to treat cancer while mitigating drug-induced cardiac arrhythmia and cardiac damage, enabling its customers to receive chemotherapy without … WebSignpath Pharma is a development stage biotechnology company founded in 2006. Its lead compound is 99.2% pure synthesized curcumin (diferuloylmethane). Curcumin has an …

WebSignpath Pharma is a clinical-stage company with a drug development platform that creates heart-safe drugs. It is based in Sandy, Utah. Headquarters Location. 7984 South 1300 East . Sandy, Utah, 84094, United States. Suggest an edit. Missing: Signpath Pharma's Product Demo & Case Studies. WebSignPath Pharma is a biotechnology company. It develops products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a common side effect of many drugs, …

WebApr 27, 2024 · On March 17, 2024, SignPath Pharma issued a press release stating its intention to pursue a therapeutic treatment for COVID-19 with SignPath’s proprie. On …

Websignpath pharma inc. 6,161,448 Shares of common stock This prospectus relates to the public offering of up to 6,161,448 shares of our common stock consisting of 1,507,500 shares issued to seventeen (17) retail accredited investors in a bridge financing and 4,653,948 shares issuable upon conversion and exercise of securities sold to 33 different … how fix tire pressure monitorWeb31 Oct 2024 SignPath Pharma intends to conduct further clinical trials of liposomal curcumin, in 2024 ; Subscriber content You need to be a logged in subscriber to view this content. If your organization has a subscription then there are several options available to help you access AdisInsight, even while ... highest 4k fpsWebSignPath Pharma is a biotechnology company. It develops products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a common side effect of many drugs, and heart muscle damage caused by chemotherapy. how fix toilet flapperWebSignPath Pharma Inc operates as a biotechnology company. The Company researches curcumin, a compound that occurs in the tumeric plant, as a treatment for malignant … how fix the red screen of deathWebSignPath Pharma Inc. Quarterly Report on Form 10-Q. Period Ended March 10, 2010 . Table of Contents . Page. PART I . FINANCIAL INFORMATION . Item 1. Financial Statements: Condensed Balance Sheets as of March 31, 2010 (unaudited) and December 31, … highest 4 star sword base attackWebSignPath Pharma, Inc. is a company that provides Pharmacy and Therapeutics, Curcumin, Curcuminoid and more. SignPath Pharma, Inc. is headquartered in United States Pennsylvania. SignPath Pharma, Inc. was founded in 2006. SignPath Pharma, Inc. has a total of 176 patents and 1 literature. highest 4th innings chase in cape townhighest 4 star base attack genshin